Pregabalin Capsule
Product Images NDC 82804-170

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 82804-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-170-60 (Image 01)

This text provides information about a medication called Pregabalin 75mg in capsule form. It includes details about the packaging, dosage, expiration date, manufacturer (Proficient Rx LP), and the storage instructions (20°-25°C). The text also mentions the importance of dispensing the accompanying Medication Guide to each patient and keeping the medication out of the reach of children.*

FDA Label Image

Pregabalinfigure1 (Pregabalinfigure1)

FDA Label Image

Pregabalinfigure10 (Pregabalinfigure10)

FDA Label Image

Pregabalinfigure11 (Pregabalinfigure11)

FDA Label Image

Pregabalinfigure12 (Pregabalinfigure12)

FDA Label Image

Pregabalinfigure2 (Pregabalinfigure2)

FDA Label Image

Pregabalinfigure3 (Pregabalinfigure3)

FDA Label Image

Pregabalinfigure4 (Pregabalinfigure4)

This text presents data on the improvement of patients taking Pregabalin at different doses compared to a placebo. The chart displays the percentage of improvement in pain from baseline over a period of time. The results suggest that Pregabalin at 200 mg three times a day and 100 mg three times a day may lead to improvement, while the placebo group shows lower improvement rates.*

FDA Label Image

Pregabalinfigure5 (Pregabalinfigure5)

FDA Label Image

Pregabalinfigure6 (Pregabalinfigure6)

FDA Label Image

Pregabalinfigure7 (Pregabalinfigure7)

FDA Label Image

Pregabalinfigure8 (Pregabalinfigure8)

This text provides information about responder rates in a study, with percentages ranging from 22.6% to 40.6%. The study includes a placebo group and two dosages (2.5 mg/kg/day and 10 mg/kg/day) with corresponding participant numbers (103 and 96, respectively).*

FDA Label Image

Pregabalinfigure9 (Pregabalinfigure9)

This data provides information on the percentage of patients who showed improvement in pain at different doses of Pregabalin and the placebo. The chart displays the percent improvement in pain from baseline, showing the impact of Pregabalin at doses of 300mg, 450mg, and 600mg per day compared to the placebo.*

FDA Label Image

Pregabalinstructure (Pregabalinstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.